(Pentan-2-yl)(1-{[1,2,4]triazolo[4,3-a]pyridin-3-yl}ethyl)amine hydrochloride

Catalog No. :
ACUBTN806
CAS No. :
1240528-58-8
Molecular Formula :
C13H21ClN4
Molecular Weight :
268.79

IUPAC Name:N-(1-([1,2,4]triazolo[4,3-a]pyridin-3-yl)ethyl)pentan-2-amine hydrochloride

(Pentan-2-yl)(1-{[1,2,4]triazolo[4,3-a]pyridin-3-yl}ethyl)amine hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$310.00Login to see priceInquiryInquiry
5g95%$935.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(Pentan-2-yl)(1-{[1,2,4]triazolo[4,3-a]pyridin-3-yl}ethyl)amine hydrochloride
IUPAC NameN-(1-([1,2,4]triazolo[4,3-a]pyridin-3-yl)ethyl)pentan-2-amine hydrochloride
MDL No.MFCD16622042
Molecular FormulaC13H21ClN4
Molecular Weight268.79
SMILESCC(NC(CCC)C)C1=NN=C2C=CC=CN21.[H]Cl
InChI KeyOHGNMHYILPQUIU-UHFFFAOYSA-N
Synonym(Pentan-2-yl)(1-{[1,2,4]triazolo[4,3-a]pyridin-3-yl}ethyl)amine hydrochloride;n-(1-([1,2,4]triazolo[4,3-a]pyridin-3-yl)ethyl)pentan-2-amine hydrochloride
CAS No.1240528-58-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362

Synthetic Route by SureRoute

1. ACUBTN806 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHJOM470 route compound structure diagram
    ACHJOM470900641-16-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACUBTN806 route product structure diagram
    ACUBTN8061240528-58-8
Inquiry

2. ACUBTN806 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACUBTN806 route product structure diagram
    ACUBTN8061240528-58-8
Inquiry

Comments (0)